Tuesday, 4 April 2017

Brain-zapping wearable significantly boosts survival rates for cancer patients

NovoCure's device was first approved by the US Food and Drug Administration in 2011 for use ...

Tumor-treating fields (TTFields) are a relatively new form of cancer treatment that send mild electrical fields through the scalp in an effort to block cell division. While it was approved a few years ago, further studies have been ongoing to determine how effective it really is. New results from a clinical trial have found that it significantly improves survival rates in brain cancer patients, with scientists labelling it a once-in-a-decade advance in the area.

.. Continue Reading Brain-zapping wearable significantly boosts survival rates for cancer patients

Category: Medical

Tags: Related Articles:

from New Atlas http://ift.tt/2nG0IDd

No comments:

Post a Comment